NCT01612143View on ClinicalTrials.gov

A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

setrobuvir

200 mg capsule formulation, single oral dose

DRUG

setrobuvir

200 mg tablet formulation, single oral dose

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01612143 - A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy Volunteers | Biotech Hunter | Biotech Hunter